Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety ProfilesBoshi Huang, Xinyong Liu, Wen‐Ming Chen et al.|Journal of Medicinal Chemistry|2019Cited by 77
Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIsDongwei Kang, Xinyong Liu, Da Feng et al.|Acta Pharmaceutica Sinica B|2019Cited by 51
Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs DiscoveryDongwei Kang, Xinyong Liu, Zhao Wang et al.|ACS Medicinal Chemistry Letters|2018Cited by 33
Discovery of piperidine-substituted thiazolo[5,4-d]pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitorsDongwei Kang, Xinyong Liu, Tong Zhao et al.|Communications Chemistry|2019Cited by 32
VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditionsOsheiza Abdulmalik, Martin K. Safo, Piyusha P. Pagare et al.|Scientific Reports|2020Cited by 25